drugset / Trial / NCT02832999
Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
Phase 4
Completed
14 enrolled
Yaounde Central Hospital
University of Buea · collabUniversity of Yaounde 1 · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a single blind randomised controlled clinical trial in uncontrolled type 2 Diabetes mellitus patients on oral glucose lowering agents, and naive to incretinomimetic. Participants will be randomised in two Arms : arm 1 receiving Liraglutide at 1,2 mg/day and arm 2 Vildagliptine at 100mg/day over 14 days. The two arms will be compared for 14-day changes in insulin secretion and insulin sensitivity.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-09
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 1.2 mg | Subcutaneous |
| Comparator | Vildagliptin | Other / unclassified | 100 mg | — |